NCT03621007View on ClinicalTrials.gov

An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC, PCSK1 or LEPR Genes

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 6, 2019

Primary Completion Date

January 22, 2021

Study Completion Date

January 22, 2021

Conditions

POMC Deficiency ObesityPCSK1 Deficiency ObesityLEPR Deficiency Obesity

Trial Locations (3)

34899

Pediatric Endocrinology and Diabetes Marmara University Hospital, Istanbul

35040

Ege University School of Medicine of Pediatric Endocrinology, Bornova

35340

Dokuz Eylul Universitesi Tip Fakultesi, Balçova

All Listed Sponsors

lead

Rhythm Pharmaceuticals, Inc.

INDUSTRY

NCT03621007 - An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC, PCSK1 or LEPR Genes | Biotech Hunter | Biotech Hunter